about
The Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide AnalogsAnti-HBV Drugs: Progress, Unmet Needs, and New HopeAssociation of preexisting drug-resistance mutations and treatment failure in hepatitis B patientsPAComplex: a web server to infer peptide antigen families and binding models from TCR-pMHC complexes.Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfectionComparison of three Roche hepatitis B virus viral load assay formatsA novel pyridazinone derivative inhibits hepatitis B virus replication by inducing genome-free capsid formationAntiviral therapies: focus on hepatitis B reverse transcriptaseA Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro.Baseline characteristics of HIV & hepatitis B virus (HIV/HBV) co-infected patients from Kolkata, India.A Tat-conjugated Peptide Nucleic Acid Tat-PNA-DR Inhibits Hepatitis B Virus Replication In Vitro and In Vivo by Targeting LTR Direct Repeats of HBV RNA.Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.Seroprevalence of Hepatitis B and C Viruses Among Children in Kilimanjaro Region, Tanzania.Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapyLarge-scale production and structural and biophysical characterizations of the human hepatitis B virus polymerase.Clinical impact of hepatitis B and C virus envelope glycoproteins.Antihepatitis B therapy: a review of current medications and novel small molecule inhibitors.Hepatitis B: treatment choice and monitoring for response and resistance.New Anti-HBV C-Boivinopyranosyl Flavones from Alternanthera philoxeroides.Study on 2-arylthio-5-iodo pyrimidine derivatives as novel nonnucleoside inhibitors against hepatitis B virus DNA replication.Modulation of Wnt signaling pathway by hepatitis B virus.CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X.A Series of Oleanolic Acid Derivatives as Anti-Hepatitis B Virus Agents: Design, Synthesis, and in Vitro and in Vivo Biological Evaluation.Establishment and application of hepatitis B virus persistent replication model in IFNAR(-/-) mouse.miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes.Performance verification and comparison of TianLong automatic hypersensitive hepatitis B virus DNA quantification system with Roche CAP/CTM system.Effects of Rubiadin isolated from Prismatomeris connata on anti-hepatitis B virus activity in vitro.The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing.Inhibition of HBV replication by VPS4B and its dominant negative mutant VPS4B-K180Q in vivo.Design and synthesis of pyridine-pyrazole-sulfonate derivatives as potential anti-HBV agents
P2860
Q26781795-55CB113D-EFCD-4D49-83BD-B2FF529F1B47Q26782742-D4BF4578-5E5F-4C7E-8F09-4C618EDE19DDQ28535003-23225A00-808A-44C4-B4F5-D5B58B2043CBQ35075684-2AF806BD-E2C5-4459-AF14-B0B123906EE9Q36031673-457E9A02-EDEB-4735-B455-F9784B2DBA1AQ36118661-646FBDD1-3F95-4042-8498-D18E31759D38Q36158466-284748C6-FDD3-43C2-80F1-A43C5AA2E686Q36467514-DF38D0BC-E762-4B03-8129-7B97E6739A52Q36946907-4087C808-617D-4EC6-911B-AEE69C1FB809Q37186594-EDA52861-A707-4AC3-9637-C36A72110360Q37238749-7546E7AC-2F47-465A-AAE9-7E40F0F819D9Q37375386-14337B5E-632A-482D-A4C2-BF908C349F18Q37406752-F46FCE18-B9D2-4F6E-85CA-41FD60F2934DQ37632321-81BF385F-2CD4-4FFA-8415-C956A1C9813FQ37644005-86044F3C-6157-431E-9068-D3851F7F7872Q38083515-0271603D-1401-4F79-9BAA-977194D3F539Q38151881-538E25B1-D4E5-458C-9845-D20BBEA3299EQ38707903-815C766B-55F4-4137-95D5-E6A2824326F1Q38785600-7B2954D4-8979-4D74-86FF-80E49420BD19Q38867984-475DA01B-A331-4B92-AED3-E88DCBF94723Q39419969-AF2E1144-DAAD-438F-A13C-952C22F71F30Q40580426-F7DF2708-EE4C-46EC-97B6-1648073CC9D0Q40737218-07198639-E5CC-43A2-9ED2-BE9341E26BCEQ42258766-9703296E-E503-4192-BCC1-EC08FCABBC97Q42281174-A5771A01-1105-4A57-8279-0144202844A1Q45325498-2586E230-FCFE-47FA-83CF-B492AD8D9F7AQ45326143-6D3AB169-0CB8-4E73-8C29-3B728586ABECQ46490867-F7F9E3D8-841C-4AEA-9F36-E53D5F9C03DFQ55056246-B7D45BF0-B1A1-4747-9195-D7A7CD978EA7Q57084513-45F184D4-3D21-4AFD-8811-697A4FFA2F2A
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Review of hepatitis B therapeutics.
@ast
Review of hepatitis B therapeutics.
@en
Review of hepatitis B therapeutics.
@nl
type
label
Review of hepatitis B therapeutics.
@ast
Review of hepatitis B therapeutics.
@en
Review of hepatitis B therapeutics.
@nl
prefLabel
Review of hepatitis B therapeutics.
@ast
Review of hepatitis B therapeutics.
@en
Review of hepatitis B therapeutics.
@nl
P2860
P356
P1476
Review of hepatitis B therapeutics.
@en
P2093
Chloe L Thio
Debika Bhattacharya
P2860
P304
P356
10.1086/656624
P407
P577
2010-10-18T00:00:00Z